D‘Avila-Mesquita et al. reported that in COVID-19 patients with a severe inflammatory state, MMP-2 activity was reduced, in agreement with previous studies which report reduced levels of MMP-2 in patients with clinical signs of sepsis [84,85]. This evidence concerns the gene MMP2 and COVID-19.